Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide, an oral anti-androgen therapy, is effective in treating female pattern hair loss, even without systemic androgen excess.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Men using 5-alpha reductase inhibitors for prostate issues may have a slightly higher risk of blood clots.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Low-dose oral minoxidil alone is effective for treating hair loss, but combining it with dutasteride or finasteride may offer better results.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

Finasteride reduces prostate size, improves urination, and slows prostate cancer progression.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Testosterone therapy can safely and effectively treat symptoms like low libido and fatigue in women, especially after menopause.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Mesotherapy helps treat male hair loss effectively.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Antiandrogen treatment can reduce sexual enjoyment in women with excess male hormones, especially those in stable relationships.

Surgical removal of an adrenal tumor resolved hormonal issues in a young woman.

Ovulation inhibitors effectively treat menstrual issues and improve fertility but can have side effects.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.